News - 13 October 2014

Global Biopharmaceutical Services Organization Plans Nottingham Expansion

In 2015, biopharmaceutical services organization PAREXEL International Corporation will be moving into new premises in the city of Nottingham, securing space at the Castle Wharf development in a landmark deal that will bring new jobs to the city.

The global firm works closely with pharmaceutical companies to bring new discoveries to market, making PAREXEL the ideal company for a city that prides itself on a history of medical innovation. The move will see the company rationalising its presence at several sites into the new city centre HQ.

PAREXEL is a leading global biopharmaceutical services organization, providing knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.  PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 75 locations in 50 countries around the world, and has approximately 15,335 employees. 

The company has secured two grants from the Nottingham Technology Grant Fund (N’Tech) to support its move into Castle Wharf, the former site of BT. The grants will help ensure the continued development of the Nottingham location as a global research centre and support PAREXEL’s development of innovative new technologies for managing clinical trials.  N’Tech funding is run by Nottingham City Council and supported solely through the Government’s Regional Growth Fund (RGF).

“PAREXEL’s Nottingham operations play an important role in helping the Company advance the worldwide success of the biopharmaceutical and medical device industries in preventing and curing disease,” the Company said in a statement. “We are pleased to have received grants from the Nottingham Technology Grant Fund to support our move and appreciate the support of the Nottingham City Council as we expand our local presence.”

PAREXEL has been in negotiations with Nottingham City Council and the Invest in Nottingham team over several months to expand the company’s operations in the city and support its move.

Speaking about the investment, Councillor Jon Collins, Leader of Nottingham City Council said: “We are delighted with the announcement that PAREXEL will be expanding in the city. They are a company of international standing and also part of the life sciences industry, which is a strong point and a priority growth sector for the city. In Nottingham we have a long history of innovation in science, and as the city where Ibuprofen and the MRI scanner were invented, our record of breakthroughs makes us the perfect location for PAREXEL. There are some exciting developments ahead that will benefit the sector and the city as a whole.”

Latest News & Events

29 November 2023

D2N2 LEP Annual Event and AGM, 7 December 2023 12 – 2.30pm: last call for registrations

Read Article

22 November 2023

D2N2 LEP welcomes the announcement of an East Midlands Investment Zone in the Chancellor’s Autumn Statement

Read Article

22 November 2023

Creative businesses in Nottingham and Nottinghamshire set to benefit from funding to help them thrive

Read Article

16 November 2023

New showreel videos promote the impact of the D2N2 Growth Hub

Read Article

15 November 2023

Charter for Inclusive Entrepreneurship, supported by D2N2, launches nationally to minimise barriers to business for under-represented groups

Read Article

10 November 2023

D2N2 LEP Chair, Elizabeth Fagan, shares her thoughts on the strategy and plans for East Midlands devolution, on track to happen in Spring 2024

Read Article

10 November 2023

David Williams, Deputy Chair of D2N2 LEP, receives his MBE in Derbyshire

Read Article

30 October 2023

Mark Rogers, Interim Chief Officer for the East Midlands Devolution Programme, to speak at D2N2 Annual Event and AGM

Read Article

27 October 2023

Milestone achieved for East Midlands devolution

Read Article

26 October 2023

D2N2 Connected Futures partnership featured in London showcase

Read Article

Get in touch.

Subscribe to our newsletter

Sign up
Address

D2N2 Local Enterprise Partnership
8 Experian Way
Nottingham
Nottinghamshire
NG2 1EP

Social

Our Partners